tiprankstipranks
Mydecine Innovations Group (TSE:MYCO)
CNQX:MYCO

Mydecine Innovations Group (MYCO) Ownership - Who Owns Mydecine Innovations Group?

83 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Jan 12, 2024
David Joshua Bartch
Chief Executive Officer
BoughtC$18480
Jan 06, 2024
David Joshua Bartch
Chief Executive Officer
BoughtC$15000
May 09, 2023
Damon Michaels
Chief Operating Officer
SoldC$16140

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
23,185,565.00Insider44.11%231,855.65
11,033,170.00Insider20.99%110,331.70
7,465,000.00Insider14.20%74,650.00
6,675,000.00Insider12.70%66,750.00
5,886,260.00Insider11.20%58,862.60
5,108,298.00Insider9.72%51,082.98
1,475,979.00Insider2.81%14,759.79
318,354.00Insider0.61%3,183.54
231,497.00Insider0.44%2,314.97
90,883.00Insider0.17%908.83

Top Mutual Fund Holders

Currently, No Data Available
Holder
# of Shares
Type
% Holding
Value

Top ETF Holders

Currently, No Data Available
Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns Mydecine Innovations Group (TSE:MYCO)?
Currently, no data Available
What percentage of Mydecine Innovations Group (TSE:MYCO) stock is held by institutional investors?
Currently, no data Available
What percentage of Mydecine Innovations Group (TSE:MYCO) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Mydecine Innovations Group (TSE:MYCO)?
Carman Parente owns the most shares of Mydecine Innovations Group (TSE:MYCO).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis